Date	Period	Revenue/Estimate	Earnings Call
May 13, 2024	2024/FY	5.551B / --	--
May 10, 2023	2023/FY	4.755B / --	--
May 12, 2022	2022/FY	4.950B / --	--
May 12, 2021	2021/FY	5.154B / --	--
May 13, 2020	2020/FY	4.697B / --	--

DatePeriodRevenue/EstimateEarnings Call

May 13, 20242024/FY5.551B / ----

May 10, 20232023/FY4.755B / ----

May 12, 20222022/FY4.950B / ----

May 12, 20212021/FY5.154B / ----

May 13, 20202020/FY4.697B / ----

Unlock Free Earnings Estimates

Open Account

Kanda Tsushinki Earnings Reports

Kanda Tsushinki: Confirmation letter

Nov 13, 2024 21:06 ET

Kanda Tsushinki: Half Year Report - Term 88 (2024/04/01 - 2025/03/31)

Nov 13, 2024 21:05 ET

Kanda Tsushinki: Summary of financial results for the 2nd quarter (interim period) of the fiscal year ending 2025/3 [Japanese GAAP] (Consolidated)

Nov 11, 2024 01:30 ET

Kanda Tsushinki: Notice regarding differences between consolidated earnings forecasts and actual results for the 2nd quarter (interim period) of the fiscal year ending March 31, 2025

Nov 11, 2024 01:30 ET

Symbol Price % Chg

D. Western Therapeutics Institute

4576

201 +23.31%

See the daily top gainer.